Aridis Pharmaceuticals (ARDS) Stock Chart & Stock Price History Add Compare Share Share Chart Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock Aridis Pharmaceuticals Stock Price Performance The Aridis Pharmaceuticals (ARDS) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock decreased 100.00%. In the past month, the stock has decreased 100.00%, reflecting recent market activity.Five years ago, the stock traded at $7.30, representing a 100.00% decrease over that period. At the time, it had a market cap of $65.12 million and a volume of 10,187 shares. Receive ARDS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aridis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-100.00%1 Month Performance-100.00%3 Month Performance-100.00%Year-To-Date Performance-100.00%5 Year Performance-100.00% ARDS Stock Chart for Thursday, August, 28, 2025 ARDS Chart by TradingView Aridis Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/25/2025$0.00$0.00$0.00$0.0021,814 shs$5,000.0008/22/2025$0.00$0.00$0.00$0.0021,814 shs$5,000.0008/21/2025$0.00$0.00-50.00%$0.00$0.00951 shs$5,000.0008/20/2025$0.00$0.00$0.00$0.0010,221 shs$11,000.0008/19/2025$0.00$0.00+100.00%$0.00$0.002,420 shs$11,000.0008/18/2025N/A$0.00$0.00$0.0038,417 shs$5,000.0008/15/2025$0.00$0.00$0.00$0.004,488 shs$5,000.0008/14/2025N/A$0.00$0.00$0.004,488 shs$5,000.0008/12/2025$0.00$0.00$0.00$0.00236,100 shs$5,000.0008/11/2025N/A$0.00$0.00$0.00236,100 shs$5,000.00 Get the Latest News and Ratings for ARDS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aridis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 08/06/2025$0.00$0.00$0.01$0.001,505 shs$5,000.0008/05/2025$0.00$0.00$0.01$0.001,505 shs$5,000.0008/04/2025$0.00$0.00$0.01$0.001,505 shs$5,000.0008/01/2025$0.00$0.00$0.00$0.0030,065 shs$5,000.0007/31/2025$0.00$0.00$0.00$0.005,525 shs$5,000.0007/30/2025$0.00$0.00$0.00$0.005,525 shs$5,000.0007/29/2025$0.00$0.00$0.00$0.005,525 shs$5,000.0007/28/2025$0.00$0.00$0.00$0.005,525 shs$5,000.00 Related Companies VRPX Stock Price Chart STAB Stock Price Chart EVLO Stock Price Chart CMRA Stock Price Chart GNCAQ Stock Price Chart GNCA Stock Price Chart AMPE Stock Price Chart PXMD Stock Price Chart CALA Stock Price Chart CLVR Stock Price Chart Receive ARDS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aridis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ARDS) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredSmall Washington, DC Group Could Crash US StocksNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aridis Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aridis Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access